# IA Carboplatin + Radiotherapy in Relapsing GBM

> **NCT03672721** · PHASE1,PHASE2 · RECRUITING · sponsor: **Université de Sherbrooke** · enrollment: 35 (estimated)

## Conditions studied

- Glioblastoma Multiforme
- Relapse

## Interventions

- **DRUG:** IA Carbo+ Radiation

## Key facts

- **NCT ID:** NCT03672721
- **Lead sponsor:** Université de Sherbrooke
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-07-10
- **Primary completion:** 2025-12-10
- **Final completion:** 2026-06-10
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2025-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03672721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03672721, "IA Carboplatin + Radiotherapy in Relapsing GBM". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03672721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*